INS and fatty liver disease: FGF1 is another secreted protein that has been shown to dampen hepatic glucose output by suppressing adipose lipolysis (78), improve systemic insulin sensitivity by reducing adipose inflammation (79), and alleviate hepatic steatosis, inflammation, and insulin resistance (80).